Table 5.
Covariates | Levels | ERR (95 % CI) |
---|---|---|
Schistosoma haematobium dataset | ||
(Baseline) | Côte d’Ivoire; male; younger SAC; 40 mg/kg; 21 days follow-up | 99.7 % (97.4 %, 100 %) |
Country | Kenyaa | 99.8 % (98.8 %, 100 %) |
Sex | Female | 99.7 % (95.7 %, 100 %) |
Age group | Older SAC | 95.9 % (85.8 %, 98.8 %) |
Schistosoma mansoni dataset | ||
(Baseline) | Côte d’Ivoire; male; younger SAC; 40 mg/kg; 21 days follow-up | 95.4 % (83.1 %, 98.8 %) |
Country | Uganda | 85.3 % (73.5 %, 91.8 %) |
Dose | 60 mg/kg | 98.5 % (90.8 %, 99.8 %) |
Sex | Female | 93.2 % (74.1 %, 98.2 %) |
Age group | Pre-SAC | 95.3 % (80.9 %, 98.8 %) |
Older SAC | 96.6 % (85.8 %, 99.2 %) | |
Follow-up time | 28 days | 84.9 % (76.7 %, 90.1 %) |
42 days | 73.6 % (53.2 %, 85.1 %) |
Abbreviations: CI confidence intervals, SAC school-age children
aChildren in Kenya were followed up for 42 days